Novel Therapies for Diabetic Kidney Disease: Storied Past and Forward Paths

Area of Science:

• Nephrology
• Endocrinology
• Pharmacology

Background:

• Diabetic kidney disease (DKD) is a growing global health concern.
• Current therapeutic strategies offer only moderate success in halting DKD progression.
• There is a critical need for innovative treatments to manage this condition.

Purpose of the Study:

• To highlight the urgent need for novel therapies for diabetic kidney disease (DKD).
• To identify emerging therapeutic targets based on a deeper understanding of DKD pathogenesis.
• To discuss challenges and potential solutions for the clinical translation of these novel therapies.

Main Methods:

• Review of current understanding of DKD pathogenesis.
• Identification of molecular targets such as advanced glycation end products, reactive oxygen species, protein kinase C, and serum amyloid A.
• Analysis of challenges in translating experimental findings into clinical practice.

Main Results:

• Several molecular targets show promise for DKD treatment based on experimental data.
• Clinical translation of potential therapies is hindered by existing barriers.
• Advances in preclinical evaluation and drug delivery systems are crucial.

Conclusions:

• Novel therapeutic targets for DKD have been identified through enhanced understanding of its mechanisms.
• Overcoming clinical translation challenges is essential for developing new DKD treatments.
• Improved preclinical assessments and delivery methods are vital for therapeutic success.